Jacob Johnson analyst

Currently out of the existing stock ratings of Jacob Johnson, 108 are a BUY (77.7%), 31 are a HOLD (22.3%).

Jacob Johnson

Work Performance Price Targets & Ratings Chart

Analyst Jacob Johnson, carries an average stock price target met ratio of 60.69% that have a potential upside of 30.9% achieved within 156 days. Previously, Jacob Johnson worked at STEPHENS.

Jacob Johnson’s has documented 268 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on STE, STERIS plc at 06-Feb-2025.

Wall Street Analyst Jacob Johnson

Analyst best performing recommendations are on LFCR (LIFECORE BIOMEDICAL).
The best stock recommendation documented was for CYRX (CRYOPORT) at 8/24/2020. The price target of $44 was fulfilled within 2 days with a profit of $7.32 (19.96%) receiving and performance score of 99.78.

Average potential price target upside

AZTA Azenta BLFS BioLife Solutions BRKS Brooks Automation CD Chindata Group Holdings Ltd CDMO Avid Bioservices DHR Danaher LFCR Lifecore Biomedical MASS 908 Devices MXCT MaxCyte REPH Recro Pharma RGEN Repligen STE STERIS plc TKNO Alpha Teknova TMO Thermo Fisher Scientific CDXS Codexis CERS Cerus CTLT Catalent CYRX Cryoport LGND Ligand Pharmaceuticals NEO NeoGenomics OSUR OraSure Technologies STVN Stevanato Group SpA TDOC Teladoc TECH Bio-Techne Corp WST West Pharmaceutical Services LNDC Landec

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-May-2021

$37

$-1.75 (-4.52%)

$37

19 days ago
(14-Sep-2026)

7/31 (22.58%)

$4.96 (15.48%)

100

Buy Since 05-Feb-2026

$35

$-3.75 (-9.68%)

$35

1 months 27 days ago
(06-Aug-2026)

12/15 (80%)

$4.26 (13.86%)

84

Buy Since 04-Feb-2026

$40

$14.5 (56.86%)

$38

7 months 28 days ago
(04-Feb-2026)

1/3 (33.33%)

$11.51 (40.40%)

26

Hold Since 27-Feb-2025

$39

$13.5 (52.94%)

$35

8 months 24 days ago
(08-Jan-2026)

3/4 (75%)

$1.5 (4.00%)

36

Buy Since 25-Nov-2025

$45

$19.5 (76.47%)

$35

10 months 7 days ago
(25-Nov-2025)

1/2 (50%)

$6.9 (18.11%)

110

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?